Patents by Inventor John A. Rogers

John A. Rogers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200188657
    Abstract: A system for stimulating tissue generally comprises a resorbable implant. The resorbable implant includes a substrate, at least one contact, and a transceiver, wherein the substrate, the at least one contact, and the transceiver are resorbable. The system also includes a controller configured to communicate with the transceiver of the resorbable implant and a power supply connected to the controller. The controller delivers power to the resorbable implant from the power supply. The resorbable implant delivers electrical stimulation to tissue when the resorbable implant receives power.
    Type: Application
    Filed: April 25, 2018
    Publication date: June 18, 2020
    Inventors: Wilson Z. Ray, Matthew R. MacEwan, Zohny S. Zohny, John A. Rogers
  • Patent number: 10686842
    Abstract: A method for providing an administration policy to a user device comprising a plurality of applications, the method comprising centrally generating the administration policy to be implemented in the user device, the administration policy comprising at least one of an application administration policy to be used by at least one of the plurality of applications and a client administration policy for the user device; and providing the generated policy to the user device.
    Type: Grant
    Filed: November 22, 2018
    Date of Patent: June 16, 2020
    Assignee: BlackBerry Limited
    Inventors: Kenneth John Wallis, Bryan Richard Goring, Viera Bibr, Kamen Vitanov, Laura Brindusa Fritsch, Michael Shenfield, Jeffrey Christopher Rogers
  • Publication number: 20200184419
    Abstract: The present invention relates to methods and systems for reporting the identity of a sample sourced from an animal. In particular, the present invention relates to reporting the identity of a sample taken from a pig animal of the species Sus scrofa. More particularly, the invention relates to methods and systems for reporting the identity of an unknown pig animal sample comprising registering reference samples in a database through a register; recording data representing the reference samples; recording data representing the unknown sample and comparing the data to assess the identity of the unknown pig sample through the register.
    Type: Application
    Filed: April 30, 2018
    Publication date: June 11, 2020
    Inventors: John Roger WATLING, Garry LEE
  • Patent number: 10677647
    Abstract: The invention provides systems and methods for tissue-mounted electronics and photonics. Devices of some embodiments of the invention implement high performance, and optionally flexible, device components having miniaturized formats in device architectures that minimize adverse physical effects to tissue and/or reduce interfacial stresses when mounted on tissue surfaces. In some embodiments, the invention provides complementary tissue mounting strategies providing for mechanically robust and/or long term integration of the present devices, for example, via mounting on tissue surfaces that are not subject to rapid growth or exfoliation processes such as the fingernail, toenail, tooth or earlobe. Devices of the invention are versatile and support a broad range of applications for sensing, actuating and communication including applications for near field communication, for example, for password authentication, electronic transactions and biometric sensing.
    Type: Grant
    Filed: June 1, 2016
    Date of Patent: June 9, 2020
    Assignee: The Board of Trustees of the University of Illinois
    Inventors: John A. Rogers, Anthony R. Banks, Jeonghyun Kim, Gregory Brown
  • Patent number: 10679747
    Abstract: The present disclosure related to an apparatus that may be used for taking blood glucose measurements and providing individualized insulin dose recommendations wherein the apparatus is easy to use and facilitates improved diabetes control in patients. Also disclosed are related methods.
    Type: Grant
    Filed: April 6, 2018
    Date of Patent: June 9, 2020
    Assignee: Hygieia, Inc.
    Inventors: Holly Bielawa, Carissa Demetris, James Goebel, Carol Treat Morton, Michelle Pomorski, Thomas Puricelli, Jim Rogers, Eran Bashan, Israel Hodish, John Hindinger
  • Publication number: 20200161291
    Abstract: Provided are optical devices and systems fabricated, at least in part, via printing-based assembly and integration of device components. In specific embodiments the present invention provides light emitting systems, light collecting systems, light sensing systems and photovoltaic systems comprising printable semiconductor elements, including large area, high performance macroelectronic devices. Optical systems of the present invention comprise semiconductor elements assembled, organized and/or integrated with other device components via printing techniques that exhibit performance characteristics and functionality comparable to single crystalline semiconductor based devices fabricated using conventional high temperature processing methods. Optical systems of the present invention have device geometries and configurations, such as form factors, component densities, and component positions, accessed by printing that provide a range of useful device functionalities.
    Type: Application
    Filed: October 29, 2019
    Publication date: May 21, 2020
    Inventors: John A. ROGERS, Ralph NUZZO, Matthew MEITL, Etienne MENARD, Alfred BACA, Michael MOTALA, Jong-Hyun AHN, Sang-Il PARK, Chang-Jae YU, Heung Cho KO, Mark STOYKOVICH, Jongseung YOON
  • Publication number: 20200155047
    Abstract: Provided are microfluidic systems for monitoring a biofluid property and related methods. Specially configured microfluidic networks and associated structural support and functional elements, including flexible substrates, capping layers, and fluidic conduits and controllers, provide reliable biofluid collection. Optical components and indicators provide a reliable and readily observable readout, including of any of a number of biofluid properties, including directly from biofluid collected in the microfluidic network.
    Type: Application
    Filed: June 1, 2018
    Publication date: May 21, 2020
    Inventors: John A. ROGERS, Jungil CHOI, Tyler R. RAY, Johnathan T. REEDER, Yurina SEKINE, Amay J. BANDODKAR, Yi ZHANG, Hexia GUO, Sungbong KIM, Diana OSTOJICH
  • Patent number: 10656104
    Abstract: A system for non-destructive testing of an overhead energized electrical component. The system has a base, an X-ray source, an X-ray digital imager, and an imager controller. The system also has a removable electrically conductive flexible shield which is adapted to be operatively coupled to, and to encapsulate, at least the base, the X-ray source, the X-ray digital imager and the imager controller so as to form a shrouded system. In a use position, when the shrouded system is positioned adjacent the energized electrical component so as to non-destructively test the energized electrical component, the shield protects at least the base, the X-ray source, the X-ray digital imager and the imager controller from electric fields around the energized electrical component while allowing signal communication between at least the X-ray source and the energized electrical component.
    Type: Grant
    Filed: October 17, 2018
    Date of Patent: May 19, 2020
    Assignee: Quanta Associates, L.P.
    Inventors: James Ronald Hill, Donald Dodds, Jeffrey Victor Rogers, Calvin Edward Stock, Benjamin John William Nesbitt
  • Patent number: 10653342
    Abstract: The invention provides systems for handling biofluids including the transport, capture, collection, storage, sensing, and/or evaluation of biofluids released by tissue. Systems of some aspects provide a versatile platform for characterization of a broad range of physical and/or chemical biofluid attributes in real time and over clinically relevant timeframes. Systems of some aspects provide for collection and/or analysis of biofluids from conformal, watertight tissue interfaces over time intervals allowing for quantitative temporal and/or volumetric characterization of biofluid release, such as release rates and release volumes.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: May 19, 2020
    Assignees: The Board of Trustees of the University of Illinois, Northwestern University
    Inventors: John A. Rogers, Jungil Choi, Sungbong Kim
  • Patent number: 10647717
    Abstract: The present invention provides for compounds of formula (I) wherein R1, R2, R3, R4, R5, and R6 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions mediated and modulated by CFTR, including cystic fibrosis, Sjögren's syndrome, pancreatic insufficiency, chronic obstructive lung disease, and chronic obstructive airway disease. Also provided are pharmaceutical compositions comprised of one or more compounds of formula (I).
    Type: Grant
    Filed: June 18, 2019
    Date of Patent: May 12, 2020
    Assignees: AbbVie S.á.r.l., Galapagos NV
    Inventors: Rhalid Akkari, Luke Jonathan Alvey, Xavier Marie Bock, Brian S. Brown, Pieter Isabelle Roger Claes, Marlon D. Cowart, Elsa De Lemos, Nicolas Desroy, Béranger Duthion, Gregory A. Gfesser, Romain Luc Marie Gosmini, Christopher Gaëtan Housseman, Koen Karel Jansen, Jianguo Ji, Philip R. Kym, Jean-Michel Lefrancois, Oscar Mammoliti, Christel Jeanne Marie Menet, Nuria Merayo Merayo, Gregory John Robert Newsome, Adeline Marie Elise Palisse, Sachin V. Patel, Matthieu Rafaël Pizzonero, Anurupa Shrestha, Elizabeth C. Swift, Steven Emiel Van der Plas, Xueqing Wang, Ann de Blieck
  • Publication number: 20200129077
    Abstract: Provided are apparatuses and methods for non-invasively measuring a blood pressure of a mammal subject. The apparatus includes a first sensor system and a second sensor system time-synchronized to each other and spatially separated by a pulse arrival distance L, and a microcontroller unit (MCU). The first and second sensor systems are respectively attached to first and second positions of the mammal subject for detecting first and second signals. The second position is more distal or proximal to a heart of the mammal subject than the first position. The MCU processes the output signals to determine a pulse arrival time (PAT) as a time delay ?t between detections of the first and second signals, and determines a pulse wave velocity (PWV) based on the PAT and L, where PWV = L ? ? ? t . Then the MCU determines the blood pressure P from the PWV, where P is a parabolic function of the PWV.
    Type: Application
    Filed: October 31, 2019
    Publication date: April 30, 2020
    Inventors: John A. Rogers, Shuai Xu, Yinji Ma, Jungil Choi, Aurelie Hourlier-Fargette, Yonggang Huang
  • Publication number: 20200119706
    Abstract: An operational amplifier with totem pole connected output transistors having inputs coupled to multiplexers for selectable coupling of signals and voltage levels thereto. The high and low output transistors may be forced hard on or hard off in addition to normal coupling of signals thereto. The operation of the output transistors may be dynamically changed to pass only positive going signals, negative going signals, placed in a tristate high impedance state, hard connected to a supply voltage and/or hard connected to supply common return. A core independent peripheral (CIP) may also be coupled to the operational amplifier for dynamically changing the multiplexer inputs in real time, as can external control signals to a control circuit coupled to the multiplexers.
    Type: Application
    Filed: May 14, 2019
    Publication date: April 16, 2020
    Applicant: Microchip Technology Incorporated
    Inventors: Keith Edwin Curtis, Ward Brown, John Charais, Steve Kennelly, Dave Suda, Huamin Zhou, Clark Rogers, Mudit Gupta
  • Patent number: 10619146
    Abstract: The present invention is directed to non-cytotoxic protein conjugates for inhibition or reduction of exocytic fusion in a nociceptive sensory afferent cell. The protein conjugates comprise: (i) a Targeting Moiety (TM), wherein the TM is an agonist of a receptor present on a nociceptive sensory afferent cell, and wherein the receptor undergoes endocytosis to be incorporated into an endosome within the nociceptive sensory afferent cell; (ii) a non-cytotoxic protease or a fragment thereof, wherein the protease or protease fragment is capable of cleaving a protein of the exocytic fusion apparatus of the nociceptive sensory afferent cell; and (iii) a Translocation Domain, wherein the Translocation Domain translocates the protease or protease fragment from within the endosome, across the endosomal membrane, and into the cytosol of the nociceptive sensory afferent cell wherein the Targeting Moiety is selected from the group consisting of BAM, ?-endorphin, bradykinin, substance P, dynorphin and/or nociceptin.
    Type: Grant
    Filed: September 7, 2016
    Date of Patent: April 14, 2020
    Assignees: Ipsen Bioinnovation Limited, Allergan Inc.
    Inventors: Keith Foster, John Chaddock, Charles Penn, Kei Roger Aoki, Joseph Francis, Lance Steward
  • Patent number: 10617300
    Abstract: Provided are implantable or surface mounted biomedical devices and related methods for interfacing with a target tissue. The devices have a substrate and device component supported by the substrate. The components of the device are specially configured and packaged to be ultra-thin and mechanically compliant. In particular, device thicknesses are less than 1 mm and have lateral dimensions between about 1 m and 10 mm, depending on the application. Delivery substrates may be incorporated to assist with device implantation and handling. The devices can be shaped to provide injection in a minimally invasive manner, thereby avoiding unnecessary tissue damage and providing a platform for long-term implantation for interfacing with biological tissue.
    Type: Grant
    Filed: February 11, 2014
    Date of Patent: April 14, 2020
    Assignees: The Board of Trustees of the University of Illinois, Washington University
    Inventors: John A. Rogers, Michael Raymond Bruchas, Robert Gereau, Jordan Gary McCall, Daniel Brenner, Tae-il Kim, Gunchul Shin, Jaewoong Jeong
  • Patent number: 10614239
    Abstract: A database table, such as may be implemented by a non-relational database, is provided to present information and states associated with that information as memorialized in a cryptographically secured ledger. The semantics of the database table elements, as well as the relationships between various objects therein, may be defined and/or enforced by a schema, a database engine, and/or an application layer. For example, the disclosed methods and systems may be used to implement an asset tracking tool that does not require trust of the implementing system for verification of the system's contents.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: April 7, 2020
    Assignee: Amazon Technologies, Inc.
    Inventors: Christopher Richard Jacques de Kadt, Timothy William Bray, Trevor Simon Roger Dyck, Matthew John Campagna, Allan Henry Vermeulen
  • Publication number: 20200093416
    Abstract: Provided herein are flexible, microfluidic epidermal systems and methods useful in the analysis of biofluids for biomarkers corresponding to a variety of conditions and methods of use. The provided systems configured to create conformal contact with the skin to allow for medical testing or screening, either in situ or later external laboratory testing. The described devices and methods may be used for cystic fibrosis screening, glucose monitoring, drug and/or alcohol testing, creatinine monitoring, urea monitoring, pH measurement and dialysis treatment efficacy testing.
    Type: Application
    Filed: June 1, 2018
    Publication date: March 26, 2020
    Inventors: John A. ROGERS, Tyler R. RAY, Jungil CHOI, Yi ZHANG
  • Publication number: 20200088739
    Abstract: Provided herein are epidermal microfluidic systems and methods that allow for the collection of biofluids in a wet or aquatic environment, for example, from the surface of the skin. The described systems allow for the efficient collection of biofluids, without loss of the biofluid to the surrounding environment or introduction of extraneous liquids from the environment. The described microfluidic systems are versatile and can provide information regarding a number of biofluid properties both electronically and colorimetrically/visually.
    Type: Application
    Filed: June 1, 2018
    Publication date: March 19, 2020
    Inventors: John A. ROGERS, Jungil CHOI, Johnathan T. REEDER
  • Publication number: 20200071742
    Abstract: A method for distinguishing among a first group of microorganisms belonging to a first taxon of Gram negative bacteria, the first group of bacteria exhibiting a mechanism of resistance to a treatment; a second group of microorganisms belonging to a second taxon of Gram negative bacteria, the second taxon of bacteria being different than said first taxon, and exhibiting a mechanism of resistance to a treatment identical to the mechanism of the first group; and a third group of Gram negative bacteria that is not resistant to the treatment.
    Type: Application
    Filed: November 8, 2019
    Publication date: March 5, 2020
    Applicant: BIOMERIEUX
    Inventors: Sylvain ORENGA, Céline ROGER-DALBERT, John PERRY, Vanessa CHANTEPERDRIX, Gilles ZAMBARDI, Nathalie BAL
  • Publication number: 20200072827
    Abstract: The present invention relates to systems and methods that utilize a combination of immunoassay and magnetic immunoassay techniques to detect an analyte within an extended range of specified concentrations. In particular, a device includes a first immunosensor including an immobilized layer of capture antibodies configured to bind to a first complex of signal antibodies and cardiac troponin such that a second complex of the first complex and the immobilized layer of capture antibodies is localized on or near the first immunosensor. The device further includes a second immunosensor having a magnetic field disposed locally around the second immunosensor. The magnetic field is configured to attract magnetic beads such that a third complex of the first complex and capture antibodies immobilized on the magnetic beads is localized on or near the second immunosensor sensor.
    Type: Application
    Filed: November 11, 2019
    Publication date: March 5, 2020
    Applicant: Abbott Point of Care Inc.
    Inventors: Jing Hua Hu, Antti Leo Oskari Virtanen, Eric Edward Potter, James T.K. Smith, Cary James Miller, John Lewis Emerson Campbell, Adam Roger Moss
  • Patent number: 10577175
    Abstract: An International Organization for Standardization (ISO) shipping container 10 includes a cryogenic refrigeration system 14 for cryogenically cooling superconducting magnet(s) 12A, 12B during transit. The cryogenic refrigeration system 14 monitors the temperature and/or pressure of the superconducting magnet(s) and circulates a refrigerant to the superconducting magnet(s) to maintain cryogenic temperatures in superconducting coils. A power supply 16, provided by a transportation vehicle, connects to the cryogenic refrigeration system via a power inlet 20 which is accessible from the exterior of the shipping container. The superconducting magnet(s) are suspended within the shipping container which is then loaded onto the transportation vehicle. The external power supply is connected to the cryogenic refrigeration system such that refrigerant is circulated to a cold head 22A, 22B of each superconducting magnet.
    Type: Grant
    Filed: March 1, 2016
    Date of Patent: March 3, 2020
    Assignee: Koninklijke Philips N.V.
    Inventors: John Rogers, Eduardus Maria Bek